These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2878982)

  • 21. Modification of cardiovascular risk factors during antihypertensive treatment: current and new approach trends. The urapidil experience.
    Leonetti G
    Blood Press Suppl; 1994; 4():49-52. PubMed ID: 7804513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
    Rajzer M; Kawecka-Jaszcz K; Wojciechowska W
    Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antihypertensive drugs on lipid metabolism.
    Leren P
    Clin Ther; 1987; 9(3):326-32. PubMed ID: 2886221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New therapeutic outlooks in the treatment of the hypertensive patient].
    Ambrosioni E; Bacchelli S; Borghi C
    Ann Ital Med Int; 1995 Oct; 10 Suppl():78S-81S. PubMed ID: 8562273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of antihypertensive drugs on atherogenic factors: possible importance of drug selection in prevention of atherosclerosis.
    Spence JD
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S121-5. PubMed ID: 2409360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolic syndrome in hypertension: European society of hypertension position statement.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
    J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of hypotensive agents on the lipid composition of the blood].
    Preobrazhenskiĭ DV; Sinitsyn VE
    Ter Arkh; 1985; 57(11):138-42. PubMed ID: 2867613
    [No Abstract]   [Full Text] [Related]  

  • 30. The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.
    McAlister FA; Levine M; Zarnke KB; Campbell N; Lewanczuk R; Leenen F; Rabkin S; Wright JM; Stone J; Feldman RD; Lebel M; Honos G; Fodor G; Burgess E; Tobe S; Hamet P; Herman R; Irvine J; Culleton B; Petrella R; Touyz R;
    Can J Cardiol; 2001 May; 17(5):543-59. PubMed ID: 11381277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of hypertensive diseases in pregnancy--general recommendations and long-term oral therapy].
    Rath W
    Z Geburtshilfe Neonatol; 1997; 201(6):240-6. PubMed ID: 9491543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of antihypertensive therapy on glucose and lipid metabolism.
    Zehetgruber M; Christ G; Mundigler G; Gabriel H; Huber K
    Wien Klin Wochenschr; 1996 Dec; 108(24):775-80. PubMed ID: 9017889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent trend in the research of hypertension in Japan. The effects of antihypertensive drugs on serum lipids and lipoproteins in patients with mild to moderate hypertension].
    Goto Y; Tamachi H
    Nihon Naika Gakkai Zasshi; 1988 Dec; 77(12):1820-5. PubMed ID: 2907996
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypertension and atherosclerosis. Cause and effect, or two effects with one unknown cause?
    Bondjers G; Glukhova M; Hansson GK; Postnov YV; Reidy MA; Schwartz SM
    Circulation; 1991 Dec; 84(6 Suppl):VI2-16. PubMed ID: 1959216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypertension and arteriosclerosis].
    Pessina AC; Pauletto P; Rossi GP; Valle R
    Ann Ital Med Int; 1992; 7(3 Suppl):112S-118S. PubMed ID: 1363625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.